Tongshuan Jiuxin Tablets

A preliminary exploration was conducted on the clinical dosage of Tongshuan Jiuxin Tablets in the treatment of angina pectoris (Qi stagnation and blood stasis syndrome) of coronary heart disease, to provide a basis for the use of drugs in Phase III clinical trials, to conduct a preliminary exploration and evaluation of the clinical effectiveness, and to evaluate the clinical safety.

Healthy volunteers were selected to start with a safe initial dose to examine the tolerance and safety of Tongshuan Jiuxin Tablets in the normal human body, so as to provide a basis for formulating the dosing regimen for the Phase II clinical trial of this product.